Granted Patent B2

US 7,173,125 · App. 10/720,840 · Granted Feb 6, 2007

Abstract

Claims (34)

1. A compound that has formula (II):

or a derivative thereof, wherein:

O 1 and O 2 are each independently an oligonucleotide or an analogs thereof;

P 2 is a phosphodiester group;

S 1 is a ribose, a deoxyribose or a dideoxyribose;

B 1 is a nucleobase;

X is a protected or unprotected hydrazino group, a protected or unprotected oxyamino group, or a carbonyl derivative; and

M is a divalent group having any combination of the following groups, which can be combined in any order: arylene, heteroarylene, cycloalkylene, C(R 1 ) 2, —C(R 1 )═C(R 1 )—, >C═C(R 2 )(R 3 ), >C(R 2 )(R 3 ), —C≡C—, O, S(A) a , P(D) b (R 1 ), P(D) b (ER 1 ), N(R 1 ), >N + (R 2 )(R 3 ) and C(E); where a is 0, 1 or 2; b is 0, 1, 2 or 3; A is O or NR 1 ; D is S or O; and E is S, O or NR 1 ;

each R 1 is a monovalent group independently selected from hydrogen and M 1 -R 4 ;

each M 1 is a divalent group independently having any combination of the following groups, which groups can be combined in any order: a direct link, arylene, heteroarylene, cycloalkylene, C(R 5 ) 2, —C(R 5 )═C(R 5 )—, >C═C(R 2 )(R 3 ), >C(R 2 )(R 3 ), —C≡C—, O, S(A) a , P(D) b (R 5 ), P(D) b (ER 5 ), N(R 5 ), N(COR 5 ), >N + (R 2 )(R 3 ) and C(E); where a is 0, 1 or 2; b is 0, 1, 2 or 3; A is O or NR 5; D is S or O; and E is S, O or NR 5 ;

R 4 and R 5 are each independently selected from the group consisting of hydrogen, halo, pseudohalo, cyano, azido, nitro, SIR 6 R 7 R 8 , alkyl, alkenyl, alkynyl, haloalkyl, haloalkoxy, aryl, aralkyl, aralkenyl, aralkynyl, heteroaryl, heteroaralkyl, heteroaralkenyl, heteroaralkynyl, heterocyclyl, heterocyclylalkyl, heterocyclylalkenyl, heterocyclylalkynyl, hydroxy, alkoxy, aryloxy, aralkoxy, heteroaralkoxy and NR 9 R 10 ;

R 9 and R 10 are each independently selected from hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl and heterocyclyl;

R 2 and R 3 are selected from (i) or (ii) as follows:

(i) R 2 and R 3 are independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl and heteroaryl; or

(ii) R 2 and R 3 together form alkylene, alkenylene or cycloalkylene;

R 6 , R 7 and R 8 are each independently a monovalent group selected from hydrogen, alkyl, alkenyl, alkynyl, haloalkyl, haloalkoxy, aryl, aralkyl, aralkenyl, aralkynyl, heteroaryl, heteroaralkyl, heteroaralkenyl, heteroaralkynyl, heterocyclyl, heterocyclylalkyl, heterocyclylalkenyl, heterocyclylalkynyl, hydroxy, alkoxy, aryloxy, aralkoxy, heteroaralkoxy and NR 9 R 10 ; and

R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are unsubstituted or substituted with one or more substituents each independently selected from Z, wherein Z is selected from alkyl, alkenyl, alkynyl, aryl, cycloalkyl, cycloalkenyl, hydroxy, S(O) h R 20 , NR 20 R 21 , COOR 20 , COR 20 , CONR 20 R 21 , OC(O)NR 20 R 21 , N(R 20 )C(O)R 21 , alkoxy, aryloxy, heteroaryl, heterocyclyl, heteroaryloxy, heterocyclyloxy, aralkyl, aralkenyl, aralkynyl, heteroaralkyl, heteroaralkenyl, heteroaralkynyl, aralkoxy, heteroaralkoxy, alkoxycarbonyl, carbamoyl, thiocarbamoyl, alkoxycarbonyl, carboxyaryl, halo, pseudohalo, haloalkyl and carboxamido; h is 0, 1 or 2: and R 20 and R 21 are each independently selected from the group consisting of hydrogen, halo. pseudohalo, cyano, azido, nitro, trialkylsilyl, dialkylarylsilyl, alkyldiarylsilyl, triarylsilyl, alkyl, alkenyl, alkynyl, haloalkyl, haloalkoxy, aryl, aralkyl, aralkenyl, aralkynyl, heteroaryl, heteroaralkyl, heteroaralkenyl, heteroaralkynyl, heterocyclyl, heterocyclylalkyl, heterocyclylalkenyl, heterocyclylalkynyl, hydroxy, alkoxy, aryloxy, aralkoxy, heteroaralkoxy, amino, amido, alkylamino, dialkylamino, alkylarylamino, diarylamino and arylamino.

2. The compound of claim 1 that has any of formula:

wherein R 40 is selected from the group consisting of an oligonucleotide, H and OH; and R 41 is selected from the group consisting of H and OH.

3. The compound of claim 1 that is immobilized on a surface.

4. The compound of claim 1 that is conjugated to a second component.

5. A method for immobilizing oligonucleotides on a solid surface, comprising the step of:

reacting a compound of claim 1 or a plurality of said compounds with a solid surface; wherein:

if the compound has a hydrazino or oxyamino group, the solid surface has a carbonyl group; or

if the compound has a carbonyl group, the solid surface has a hydrazino or oxyamino group.

6. An immobilized oligonucleotide prepared by the method of claim 5 .

7. A method for formation of an oligonucleotide conjugate, comprising the step of:

reacting the compound of claim 1 with a second component to form an oligonucleotide conjugate;

wherein the compound and the second component comprise complementary groups.

8. An oligonucleotide conjugate prepared by the method of claim 7 .

9. The conjugate of claim 4 , wherein the second component is selected from the group consisting of a fluorescein, a rhodamine and a cyanine dye.

10. A method of preparation of a hydrazino, oxyamino or carbonyl modified nucleoside triphosphate, comprising the steps of: (i) derivatizing a carboxylic acid selected from an ω-carbonyl, an ω-protected hydrazino, and an ω-protected oxyamino substituted carboxylic acid as the corresponding active ester;

(ii) reacting the resulting active ester with an amino substituted nucleoside triphosphate; and

(iii) deprotecting the hydrazino or oxyamino group, if present.

Assignments (18)